The Success of the Vaccination Program in the U.S. Has Become Its Own Adversary

The Success of the Vaccination Program in the U.S. has become its own Adversary
Adam K. Spacher
San Diego Mesa College
The Success of the Vaccination Program in the U.S. has become its own Adversary
The success of immunizations in nearly irradiating disease has become an adversary in vaccination programs. There is a dissolution in a growing group of parents, which believe vaccinations for their children are unnecessary and can even be harmful. These “anti-vax” groups are misinformed and distrust the government and science that medical and public health professionals use to provide accurate information. This group has gathered information through inaccurate reading, like-minded people, and the use of social media geared towards a certain agenda. This causes an interference of the reputable information that medical professionals provide (Cacioppo & Freberg 2013). In the most recent outbreak of measles, that originated at Disney in late 2014, one study suggested that vaccination rates may have been as low as 50 percent (REUTERS 2015) in that area. At what point do we ask, “Why would anyone want to risk bringing back diseases we thought were eradicated in the United States?”
It helps to have a basic understanding of how vaccinations work. Many vaccines are made from a weakened live strain of a disease to be vaccinated against. Every vaccine is specifically designed to protect against a certain disease or multiple diseases, for instance, the polio vaccine is singular, whereas the MMR vaccine is a combination of measles, mumps and rubella. Each vaccine has a set dose (amount of the vaccine), route (injection site) and series (number of vaccinations needed). For example, MMR has a dose of 0.5ml, injected in the subcutaneous tissue and a two dose series. After the initial dose, the vaccine replicates and the immune system begins to produce antibodies against it. According to the Center for Disease Control the two doses are 97 percent effective against infection, in...